Get started
Author

Noan‐Minh Chau

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
2012 · King Pan Ng, Axel M Hillmer, et al. · Nature Medicine · 556
Identification of Novel Small Molecule Inhibitors of Hypoxia-Inducible Factor-1 That Differentially Block Hypoxia-Inducible Factor-1 Activity and Hypoxia-Inducible Factor-1α Induction in Response to Hypoxic Stress and Growth Factors
2005 · Noan-Minh Chau, Paul Rogers, et al. · Cancer Research · 147
PDF
Growth Factor-Mediated Induction of HDM2 Positively Regulates Hypoxia-Inducible Factor 1α Expression
2004 · Julia I. Bárdos, Noan-Minh Chau, et al. · Molecular and Cellular Biology · 87
Akt2: a role in breast cancer metastasis
2003 · Noan-Minh Chau, Margaret Ashcroft · Breast Cancer Research · 44
PDF
Effect of the CYP3A5 and ABCB1 genotype on exposure, clinical response and manifestation of toxicities from sunitinib in Asian patients
2015 · Y L Teo, H L Wee, et al. · The Pharmacogenomics Journal · 28
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5
Cytoreductive nephrectomy: past, present and future
2014 · Myria Galazi, Alejo Rodriguez-Vida, et al. · Expert Review of Anticancer Therapy · 3
A phase II study of nimotuzumab and CDDP concurrent with radiation in locally advanced squamous cell carcinoma of the head and neck (SCCHN).
2012 · Wan-Teck Lim, Mei-Kim Ang, et al. · Journal of Clinical Oncology · 3
Timeliness of lung cancer treatment utilizing the rapid access lung cancer clinic in a regional Australian Hospital
2019 · N.M.H. Chau · Annals of Oncology · 2
Mammalian target of rapamycin ( mTOR )‐related non‐infectious pneumonitis: a potential biomarker of clinical benefit?
2014 · Alejo Rodriguez‐Vida, Noan‐Minh Chau, et al. · British Journal of Urology · 2
PDF
Association of drug exposure with clinical response and toxicities in metastatic renal cell carcinoma patients (mRCC) receiving an alternative dosing (AD) regimen of sunitinib.
2013 · Yi Ling Teo, Xiu Ping Chue, et al. · Journal of Clinical Oncology · 1
Influence of Smoking Status on Response to EGFR TKI – A Retrospective Analysis of Reflex EGFR Mutation Testing in Asian Patients with Advanced Lung Adenocarcinomas
2012 · A. Jain, S.L. Koo, et al. · Annals of Oncology · 1
PDF
An Audit of the Use of Cabazitaxel for the Treatment of Metastatic Castrate Resistant Prostate Cancer (mCRPC) Compared with Previous Experience with ECarboF (Epirubicin, Carboplatin and 5-fluorouracil) in a Single Institution
2016 · M. Al-Bakir, S. Williams, et al. · Clinical Oncology
Toxicities and patient reported outcomes in elderly Asian patients receiving an attenuated dosing of sunitinib for metastatic renal cell carcinoma
2014 · Y.L. Teo, X.P. Chue, et al. · Journal of Geriatric Oncology
Association between clinical response and toxicities with drug exposure in an alternative dosing regimen of sunitinib.
2014 · Ravindran Kanesvaran, Yi Ling Teo, et al. · Journal of Clinical Oncology
Abstract 1911: A common BIM polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
2012 · S. Tiong Ong, King Pan Ng, et al. · Cancer Research
8606 POSTER Optimising Management Approaches for Locally Advanced Oropharyngeal Squamous Cell Carcinoma (LAOPSCC) – a Retrospective Review of Prognostic Factors and Outcomes in an Asian Tertiary Institution
2011 · D. Tai, S.H. Tan, et al. · European Journal of Cancer
Works count: 17
Citation count: 879
H-index: 5
I10-index: 5
Year
Topic
Type